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Detailed reply to reviewers: 
 
Reviewer 1 
 
This is a very nice, little paper from a highly-regarded and successful protein design group. 
It's technically sound and all the conclusions are justified. I would only suggest a couple of 
minor clarifications. 
 
Q1. On page 5 the authors describe experiments at low pH, however, it is not clear if only 
one pH was tested. 
A1: We thank the reviewer for allowing us to better clarify the experimental conditions. The 
experiments in the apo state were performed at pH 3.5. We have modified the text 
accordingly, both in the Results and Methods sections (pag 7 and 5/6, respectively). 
 
Q2. Did the authors consider any complementary methods to verify the tetrameric nature of 
any of their peptides, native MS, native gels or simple size exclusion chromatography come 
into mind. 
A2: We thank the reviewer for this suggestion. Accordingly, we performed size exclusion 
chromatography experiments. The SEC analysis has been added in the main text (Methods: 
pag. 6; Results: pag. 10; Discussion: pag. 11; Figure 7), and as supporting information 
(Figure S1 and Table S1). 
 
Q3. Figure 4 - the caption could explain the error bars (ie. number of repeats) 
A3: We changed the caption of Figure 4, and we added the following sentence: “The error 
bars indicate the standard deviation of three independent experiments”. 
  
Q4. Figure 5 looks somewhat sketchy which could be a simple reproduction problem 
A4: We apologize that the figure could look not well resolved. We changed the layout of 
Figure 5. We lowered the number of levels in the DOSY contour plot and used dotted lines 
to highlight diffusing species of interest. Further, we have provided all the figures, including 
figure 5, in .tiff format at 600 dpi resolution. 
 
Q5. Figure 6 - the caption could indicate the range of [Zn]/[protein] in (a) and clarify of 
[peptide] refers to the monomer or tetramer 
A5: The caption of Figure 6 has been changed according to the reviewer suggestions: “Zn2+-
binding properties of 4DH3. a) CD spectral changes of a 40 μM 4DH3 solution (as 
monomer concentration) upon addition of ZnSO4 (0.2 eq each) in 10 mM MES buffer pH 
6.5. The black arrow indicates the observed changes by increasing the metal:peptide ratio up 
to 2. …….”  
 
Q6. Figure 7 - indicate in the figure caption that these are simple molecular models 
A6: The required clarification has been inserted in the caption of Figure 8 (previously 
named Figure 7): “Structural differences among the designed models of 4DH3, 4DH4 and 
4DH5…...”. 
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Reviewer 2 
 
This paper describes a de novo design of metalloprotein 4DH3. The authors prepared three 
peptides and elucidated their solution properties by NMR and CD spectra. I recommend 
publishing on Biopolymers after consideration of following points. 
 
Q: In the manuscript body, CD and NMR were measured under acidic condition pH 3.5 but 
in the Figure captions of Figures 2 and 3, ‘in H2O’ or ‘in D2O’ was shown. What are these 
differences? 
A: We thank the reviewer for this comment that allowed us to better clarify the 
experimental conditions. Figures 2 and 3 refer to CD and NMR experiments of the apo 
form, performed at pH 3.5. We have modified the text accordingly, both in the Results and 
Methods sections (pag 7 and 5, respectively). For sake of clarity, this information has been 
also added in the figure captions. 
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2
Abstract 
 
De novo design provides an attractive approach, which allows one to test and refine the principles 
guiding metalloproteins in defining the geometry and reactivity of their metal ion cofactors. 
Although impressive progress has been made in designing proteins that bind transition metal ions 
including iron-sulphur clusters, the design of tetranuclear clusters with oxygen-rich environments 
remains in its infancy. In previous work, we described the design of homotetrameric four-helix 
bundles that bind tetra-Zn2+ clusters.  The crystal structures of the helical proteins were in good 
agreement with the overall design, and the metal-binding and conformational properties of the 
helical bundles in solution were consistent with the crystal structures.  However, the corresponding 
apo-proteins were not fully folded in solution.  In this work, we design three peptides, based on the 
crystal structure of the original bundles.  One of the peptides forms tetramers in aqueous solution in 
the absence of metal ions as assessed by CD and NMR.  It also binds Zn2+ in the intended 
stoichiometry.  These studies strongly suggest that the desired structure has been achieved in the 
apo state, providing evidence that the peptide is able to actively impart the designed geometry to the 
metal cluster. 
 
 
Keywords: de novo protein design, multinuclear transition metal ion clusters, coiled coils; four-
helix bundles, spectroscopic characterization.  
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3
Introduction 
De novo design of metalloproteins is an important tool for understanding how metal binding affects 
protein folding and for building novel structural and enzymatic functions in unnatural protein scaffolds.1-7 
In the last years, there have been considerable successful de novo designs of non-heme metalloproteins 
utilizing helical bundles.8-10 Indeed, design of helical bundles is advantageous as sequences of the 
constituting helices are usually based on heptad or other repeats, and the residues in the core of the 
bundles are generally converted to metal-binding sites.11-13 Mononuclear metal-binding sites have been 
successfully incorporated into de novo designed three-helix bundles resulting in different functions, such 
as zinc-mediated hydrolysis and copper redox catalysis.10,14 Di-metal sites have been built in de novo 
designed four-helix bundles with diverse catalytic functions.9,15-17 Recently, we have redesigned this 
scaffold to stabilize the radical semiquinone form of cathecols within the dizinc analogue,18 or to direct 
N-hydroxylation of arylamines or quinone trimerization by neat four-electron reduction of dioxygen at 
the diferric site.19-22 Meanwhile, lanthanide ion binding sites have been built in the cores of three-helix 
bundles and have potential as MRI contrast regents.23 It is noteworthy that uranyl ions can be extracted 
from seawater by binding to de novo designed binding site in a three-helix bundle.24 Multinuclear iron-
sulfur clusters as well as Cys-rich tetra-cadmium sites have been installed in de novo designed three-helix 
and four-helix bundles with programmable redox properties.25-28 Recently, we have de novo designed the 
first oxygen-liganded tetranuclear zinc clusters in four-helix bundles.29 
De novo design of multinuclear metal clusters in helical bundles has proven to be a difficult task, because 
the large size of multinuclear clusters affects the folding behavior of the helical bundles. Breathing and 
dissociative mechanisms have been shown to be crucial mechanisms of metal binding in helical 
bundles.30 However, multinuclear metal cofactor binding inside helical bundles is complicated by many 
factors. Firstly, the helix association state and the nuclearity/geometry of the metal complex are 
structurally and thermodynamically coupled; secondly, structural rigidity of the helical bundles renders it 
difficult to predict the effects of the ligand geometry on the global fold; thirdly, how the different shells 
of interactions around the multinuclear metal coordination site influences folding of the helical bundles.28 
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4
In our recent de novo design of tetranuclear zinc clusters in four-helix bundles, we showed by crystal 
structure analysis that two tetrameric bundles, 4DH1 and 4DH2, accommodate a tetranuclear zinc cluster 
in their core.29 However, they exhibit different folding features in solution: the signatures of helical 
structure inferred from far UV circular dichroism spectroscopy (CD) of 4DH2 increases after addition of 
zinc ions, while 4DH1 appears to be largely pre-organized and hence insensitive to zinc ions. Moreover, 
4DH1 displays different oligomerization state by analytical ultracentrifugation from the other designed 
helical bundles.29 
Based on these findings, in this work we design three new 4DH analogues with the aim of examining the 
features of this class of metalloproteins in solution. Unexpectedly, only one out of three, namely 4DH3, 
showed the expected folding and metal-binding ability as assessed by CD and Nuclear Magnetic 
Resonance (NMR) spectroscopies. We discuss the two unsuccessful designs in terms of helix-helix 
interfaces in coiled coils, suggesting the reasons for misfolding.  
The solution study of apo-4DH3 showed a monomer/tetramer equilibrium, which demonstrates the 
hydrogen bond network, observed by X-ray crystallography in our previous work, is established even in 
the absence of the metal cofactor. Moreover, the tetramer is stable in solution in the absence of metal 
ions, and hence ready to host the tetranuclear zinc cluster.  Thus, the peptide is able to actively impart the 
designed geometry to the metal cluster. 
 
Methods 
Protein design The starting backbone was generated by Coiled Coil Crick Parametrization program 
(CCCP, arteni.cs.dartmouth.edu/cccp/). 4DH1 crystallographic structure (PDB: 5WLL)29 was used 
as template in the fitting of backbone coordinates. Metal binding residues, second/third shell 
residues and hydrophobic core (a and d positions) residues were kept accordingly. Peripheral 
residues were first screened for aromatic (Trp and Tyr) residues insertion by manual screening 
through Rosetta fixed-backbone (fixbb) symmetry design module, and the best Trp/Tyr pairs were 
chosen according to their attractive and repulsive van der Waals terms.31 Subsequently, a full design 
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5
run was accomplished excluding Cys and Met residues for b, c, e, f and g positions between 
residues 1-10 and 19-26 and b, e, f and g positions between residues 12-18. 
Peptide Synthesis The 26 amino acid peptides were synthesized by automatic solid-phase synthesis 
using an ABI 433A peptide synthesizer (Applied Biosystem, Foster City, CA, USA) with Fastmoc-
protocols on a 0.2 mmol scale. The resin was a H-Rink amide ChemMatrix (Sigma), with a 
substitution level of 0.4 mmol/g. Fmoc group was removed with two 20% piperidine solution 
washings (3 and 7 minutes), and conditional washings were added upon conductivity 
measurements. Coupling was performed with a 5:5:10 equivalents of Fmoc-amino 
acid:HCTU:DIPEA solution in NMP for 40 minutes. Capping was performed after each coupling 
step with Ac2O/HOBt/DIPEA solution in NMP. Peptide cleavage was carried out with a 95:2.5:2.5 
(v/v/v 20 mL) solution of TFA:TIS:H2O for two hours. Resin was finally washed three times with 
pure TFA and the eluates concentrated by rotary evaporation. The peptides were precipitated by 
adding 5 volumes of cold diethyl ether and separated by centrifugation. Purification was 
accomplished by preparative reverse-phase HPLC on a Vydac C4 column (22x250 mm) with water 
and acetonitrile (0.1 % TFA) as eluents. Identity and purity of the peptides was assessed by 
analytical HPLC coupled to a Shimadzu ESI IT-TOF mass spectrometer. 
Circular Dichroism CD measurements were performed using a J-815 spectropolarimeter equipped 
with a thermostated cell holder (JASCO, Easton, MD, USA). CD spectra were collected at 25°C, 
from 260 to 200 nm at 0.2 nm intervals with a 20 nm min-1 scan speed, at 2.5 nm band width and at 
16 s response. Cells of 0.5, 0.1 and 0.01 cm path length were used in the measurements. Mean 
residue ellipticities θ were calculated using the equation θ = θobs/(10·l·C·n), in which θobs is the 
ellipticity measured in millidegrees, l is the path length of the cell in centimeters, C is the 
concentration in moles per liter, and n is the number of residues in the protein. Protein (monomer) 
concentration was determined by UV-Vis spectroscopy, using ε280 6990 M
-1cm-1.32 Protein stock 
solutions were freshly prepared in H2O at 1 mM concentration (pH 3.5). Upon dilution, the pH was 
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6
adjusted to 3.5 with trifluoroacetic acid. To conduct oligomerization studies, the peptide 
concentration ranged from 1 µM to 177 µM (as monomer) in 20 mM acetate buffer at pH 4.6, and 
prepared by dilution from a 0.5 mM stock solution. Mean residue ellipticity was fit as a function of 
peptide concentration using the program OriginPro. The equilibrium constant Kdiss is defined as 
[M]n/[T], in which [T] is the concentration of the oligomeric species, [M] is the concentration of 
monomer, and n is the association stoichiometry. Thus, Kdiss = n(α
n)(Cn-1)/(1 - α), where α is the 
fraction of monomer [(θobsd - θassoc)/(θmon - θassoc)] and C is the total peptide concentration. The 
values of θassoc and θmon were varied during fitting. 
NMR All solution for 1D-NMR analysis were prepared in H2O/ D2O (90:10 v/v). The apo form of 
the three analogues were analyzed at 1 mM concentration (pH 3.5). 1D-NMR spectra were acquired 
at 25 °C, on a Bruker Avance 600 spectrometer equipped with a triple resonance cryo-probe. 
Suppression of the solvent signal was accomplished by excitation sculpting sequence. 2D-DOSY 
spectrum of the 4DH3 analogue (0.5 mM) was obtained in D2O. Exponential fitting of the signal 
decay was made with the Bruker proprietary software TopSpin. 128 scans were recorded for each 
FID, with total acquisition time 4h for the experiment. The theoretical Stoke’s radius for holo-
protein was calculated with the program HYDROPRO,33 using default parameters except for: radius 
of the atomic probe 3.2 Å, temperature 298 K, solvent viscosity 0.012 poise.34 
Size-exclusion Chromatography Analytical size-exclusion chromatography (SEC) was carried out for 
the 4DH3 peptide on an AKTA FPLC (GE) fitted with a Superdex 75 column (GE; cutoff 3000-70000) 
and eluted at 10 °C with MES (20 mM, pH 6.5) / NaCl (200 mM) buffer solution, at a 0.5 mL/min flow 
rate. To analyze the association state in the holo form, the buffer solution contained also 50 µM ZnCl2. 
Peptide samples were prepared at 200 µM and 200 µL were injected. Four size standards were employed 
for calibration: blue dextran (2,000 kDa), Carbonic Anhydrase (29 kDa), Ribonuclease A (13.7 kDa), 
Aprotinin (6.5 kDa). Standard curve (Figure S1) and elution parameters (Table S1) are reported in the 
supporting information. 
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Results 
Protein design  
In this study, three new sequences were designed based on the 4DH series. Basically, four helices were 
arranged with D2 symmetry, using Crick parameters from our previous designs.
29 The 26-mer helix bears 
4 heptad repeats if we consider acetyl and amide capping at N- and C- termini, respectively. The central 
heptad repeat is occupied by the DXXH metal binding motif, where Asp and His occupy a and d 
positions, respectively (Figure 1a-b). Previous structural analysis showed that this binding motif forms a 
cuboidal zinc metal cluster of the form [Zn2+4(Nδ•His)4(µ
3-η1:η3-O2C•Asp)4] (Figure 1c). The 
tetranuclear metal ion site is surrounded by the hydrophobic core composed by Leu and Ile residues in a 
and d positions.35,36 In our previous paper,29 we were interested in the design of residues at positions c 
and g, which form extensive hydrogen-bonding networks, acting as second and third-shell ligands to the 
primary ligands in the active site (Figure 1d). It is also known that the residues at the b and e positions of 
coiled coils play significant roles in stabilizing coiled coils.37 While these residues were primarily apolar 
in the region adjacent to the active site in our previously designed peptides 4DH1 and 4DH2 (Figure 1e), 
in this work we explored the introduction of polar and electrostatic interactions.  Therefore, polar residues 
were screened at several b and e positions, as well as c and g positions distant to the active site, using the 
Rosetta symmetric fixbb module.31 Finally, aromatic residues, included to facilitate peptide concentration 
measurements, were allowed to vary at c, f and g positions.  Three sequences were chosen based on the 
rank order of their Rosetta-computed energies (Figure 1e).  Here, we present the solution properties of 
these variants. 
Initial screening of the designed peptides 
Circular dichroism spectroscopy reveals that only 4DH3 and 4DH4 fold into helical structures. CD 
spectroscopy was adopted to verify the helical global folding of the three analogues.  The peptides were 
screened in the apo-state at pH 3.5, which allows protonation of the Asp and His residues and improves 
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8
solubility.  Only 4DH3 has a significant α-helical content at this pH as determined by mean residue 
ellipticities (θ) at 192, 208 and 222 nm (Table 1 and Figure 2a, black). 4DH4 shows a lower helical 
content with respect to 4DH3 at 10 µM concentration (Figure 2a, red), whereas 4DH5 has random coil 
structure in these experimental conditions (Figure 2a, blue). Preliminary analysis of the three peptides at 
higher concentrations (0.1, 1 mM), reveals that only 4DH3 preserves its helical character, with 
concentration-dependent increase in helical content, as expected for coiled coil formation (Figure 2b-c, 
black). 4DH4 shows deepening of the minima centered at 205 and 225 nm as the concentration increases, 
characteristic of helical aggregates (Figure 2b-c, red).38 4DH5 exists as a random coil in these 
experimental conditions (Figure 2b-c, blue). 
1
H-NMR screening suggests the equilibrium between different 4DH3 oligomeric states in water. NMR 
spectra of the three analogues were acquired in water (pH 3.5) at 1 mM concentration. Spectra analysis 
substantially confirms the results obtained by the preliminary CD analysis. 
4DH5 shows sharp signals in the NH region, but they are not dispersed in the NH and Cα region, as 
would be expected for well-folded globular proteins (Figure 3, blue). These data are consistent with the 
hypothesis of a random coil structure for this analogue. 4DH4 shows a poorly defined and dispersed 
spectrum that suggests the presence of an oligomeric aggregate (Figure 3, red). 
High field shifts for methyl protons hint the formation of a well-defined hydrophobic core in 4DH3 
(Figure 3b, black). Amide signals appear well-defined and well-dispersed from 6 to 9 ppm (Figure 3a, 
black). These findings indicate the formation of a globular fold that consists of a defined number of 
associated helices, sequestering hydrophobic residues from the solvent.39  
Solution analysis of 4DH3 
Apo-4DH3 is in equilibrium between the monomer and the tetramer. Based on the above reported CD 
and NMR results, further analyses were carried out only on 4DH3. CD spectroscopy was adopted to 
evaluate the number of helices involved in the association, and to determine the thermodynamic driving 
force. At 1 mM concentration, the CD spectrum is consistent with nearly complete helix formation, 
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9
whereas at lower concentrations, the spectra are consistent with a combination of α-helix and random coil 
conformations (Figure 2, black). 
Fitting of the concentration dependence of the θ at 222 nm, with a simple tetramerization model, gave a 
Kdiss of 3.8 x 10
-16 M3 in 50 mM buffer acetate at pH 4.6, consistent with previously characterized 
tetrameric designed coiled coils (Figure 4)40,41 Fitting of the experimental data for oligomeric states other 
than four gave worse R2 values.  
As expected, when the same experiment was performed in 10 mM MES buffer at pH 6.5, only slight 
changes in the θ222 values were observed upon concentration increasing (data not shown). This finding 
reflects the behavior of the DF class of proteins, in which the thermodynamic cost of hindering four 
negatively charged residues is too high in the absence of the metal cofactor.42 
To confirm the hypothesis that 4DH3 is in equilibrium between the monomer and the tetramer states, 
DOSY-NMR analysis was performed to evaluate the diffusional properties of the associated oligomer. 
As shown in Figure 5, a single species can be observed in a 0.5 mM 4DH3 solution (in D2O, pD = 3.91), 
corresponding to a diffusion coefficient of 1.2±0.1 10-10 m2/s. Based on the hydrodynamic radius of the 
glycerol, used as an internal standard, the observed radius for 4DH3 is 16±2 Å.21 Experimental value has 
been compared to the hydrodynamic radius as calculated directly from the designed model of the 
tetramer. The theoretical radius of the holo-form has been calculated to be 19 Å from the designed 
model.33 Discrepancy between apo and holo forms is expected for this class of compounds, which reach 
the optimal fold upon metal binding at neutral pH. 
4DH3 tetramer binds up to four zinc ions. The metal binding properties of 4DH3 were analyzed by 
following the increase of helical content upon addition of zinc.42 The minimum at 222 nm of a 40 uM 
solution of 4DH3, in a 10 mM MES buffer at pH 6.5, decreased smoothly upon addition of ZnSO4, 
resembling a saturation mechanism of binding (Figure 6a). Thus, the CD titration data were fit by linear 
regression of the initial and final linear regions of the curves before and after binding saturation (Figure 
6b). The intercept of the two lines gives the peptide:metal expected ratio of 1:1 (corresponding to four 
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10
zinc ions for each tetramer). Protein aggregation and precipitation at higher concentrations, however, 
prevented investigation of the oligomeric state by NMR diffusion-oriented experiments. The association 
state of the designed peptide 4DH3 both in the apo and holo forms was then investigated by SEC. Figure 
7 summarizes the SEC results with and without ZnCl2. in the elution buffer. 4DH3 produced two well-
defined chromatographic peaks when eluted at pH 6.5 in the absence of zinc ion. The first, less intense, 
eluted peak (elution volume 15.6 mL), corresponds to an apparent molecular weight approximately 2-
fold higher than the monomer molecular weight (apparent Mw was 6000 Da). The second peak, 5-fold 
more intense than the previous, corresponds to the unfolded monomer eluting with the column volume, 
as its weight is close to the lower cutoff (3000-70000 Da), confirming the CD data under the same pH 
conditions. In the presence of zinc, 4DH3 produces a very broad, tailing peak, attributable to dissociation 
equilibria taking place into the column. Multi-peak fitting analysis was performed to elucidate the 
intermediate species. Three Gaussian curves were needed to fit the observed peak, corresponding to 
oligomerization state n = 3.4, 2.0, 0.9, respectively. 
 
Discussion 
In this work, we designed three new analogues of the 4DH series. We have previously shown that this 
class of peptides is able to fold into a homotetrameric four-helix bundle, and to host, in their core, an 
abiological metal cofactor composed by four Zn2+ ions bridged by four aspartates residues. In our two 
previous designs, solution characterization was limited by the lack of defined structure in the apo form. 
Here, we designed three new sequences by increasing the designable space of the two non-equivalent 
interfaces of the antiparallel four-helix bundle. This necessarily increases the number of sequences that 
could erroneously satisfy the desired fold, thus raising the risk of failure in such a difficult design task. In 
fact, only two out of three were found to be helical in the apo form, and only one was stable as a tetramer 
without aggregation by CD and NMR spectroscopies.  
We therefore analyzed the designed models, by direct comparison of the bundle interfaces (Figure 8). 
Interfaces between residues at b-e positions are closely related in the three analogues; however, both 
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11
4DH4 and 4DH5 would expose a Val-Ala patch on both extremities of the bundle, which could account 
for the aggregation observed for 4DH4. 4DH5, instead, shows a great divergence in the c-g interface with 
respect to the other two analogues. The main difference lies for the pair of residues 4-21. Both 4DH3 and 
4DH4 present two hydrophobic/aromatic residues (Tyr-Trp for 4DH3; Leu-Trp for 4DH4), whereas 
4DH5 does not show any hydrophobic residue in g position. 4DH series is composed by only 4 heptad 
repeats, and one of them is dedicated to metal binding, thus limiting the thermodynamic driving force for 
folding given by the Leu/Ile hydrophobic core. The lack of hydrophobic residues for 4DH5 in the c-g 
interface is therefore not completely counterbalanced by the designed ion pairs (only -0.6 kcal/mol 
each).41 
We thus calculated the free energy of tetramerization of apo-4DH3 at 25 °C, and we found it to be -21 
kcal/mol, comparable to previously designed antiparallel tetrameric coiled coils.36,40,41 This finding 
highlights that the apo form of this class of proteins is highly stable under acidic conditions and pre-
organized for metal binding. We expect that a dense network of hydrogen bonds could stabilize the 
protonated aspartates also in the apo form, as already outlined in our previous structural study and in 
other brilliant examples.43,44 At neutral pH, more than two oligomerization states are in equilibrium, as 
the metal-binding titration clearly shifted this equilibrium towards a well folded oligomeric state, with a 
saturation mechanism of binding. Interestingly, SEC analysis clearly suggests that the apo form is in 
equilibrium with a dimer intermediate at pH 6.5, which further moves to the tetrameric state upon zinc 
binding. Full conversion to the 4DH3 tetramer holo state was not observed under the explored conditions 
mostly because of dilution in the SEC column and successive dissociation equilibria. Protein 
precipitation prevented injection at higher concentration, and future designs will focus at increasing 
solubility of the holo state at neutral pH. 
 
Conclusion 
The primary goal of this work was to design new 4DH analogues, which would allow elucidating the 
behavior of this class of metalloproteins in solution. One of the three newly designed sequences, 4DH3, 
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12
adopts  the expected folding in aqueous solution. In fact, 4DH3 is stable and tetrameric both in the apo 
and the holo forms, as assessed by CD and NMR spectroscopies. We also demonstrated that for this class 
of proteins zinc binds the tetramer in solution with the desired stoichiometry, thus recovering one of the 
main features of Photosystem II, which is the ability to release and recover the metal cofactor of the 
OEC, during turnovers. This finding is crucial for the simple and sustainable development of a 
bioinspired catalyst for solar energy uptake,45 as well as the binding of abiological cofactors within de 
novo designed proteins.46-48 
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Figure Legends 
 
Figure 1. Design of tetranuclear clusters in helix bundles. a) D2-symmetrical 4DH analogues, 
bearing the DXXH metal-binding motif, have four Asp and four His residues coordinating 4 ions at 
the core. Second-shell Asp residues at the c-g interface (shown in red) are included to interact with 
the first-shell His ligands. The positions of the three orthogonal two-fold axes are also indicated. b) 
Crystal structure of 4DH1 (PDB ID 5WLL): the main chain is presented as cartoon, zinc ions as spheres, 
and coordinating residues as sticks. c) Designed tetranuclear zinc cluster, showing the relative 
orientations among the carboxylates. d) Model structure of 4DH analogues, including the first-shell 
ligands Asp12 and His16, the second-shell Asp11, and the third-shell Arg14. e) Sequence alignment of 4DH 
analogues. Coordinating residues are in bold, while b and e positions in proximity of the metal-binding 
site are underlined. 
 
Figure 2. CD characterization of the three analogues as a function of peptide concentration. a) 
Comparison of far UV CD spectra of 4DH3 (black), 4DH4 (red) and 4DH5 (blue) at 10 µM 
concentration. b) Comparison of far UV CD spectra of 4DH3 (black), 4DH4 (red) and 4DH5 (blue) 
at 100 µM concentration. c) Comparison of far UV CD spectra of 4DH3 (black), 4DH4 (red) and 
4DH5 (blue) at 1 mM concentration. All experiments were performed in H2O at pH 3.5. 
 
Figure 3. NMR characterization of the three analogues, 1 mM in H2O/ D2O (90:10 v/v), pH 3.5. a) 
The 1D 1H NMR spectra in the NH region of 4DH3 (top in black), 4DH4 (middle in red) and 4DH5 
(bottom in blue). b) The 1D 1H NMR spectra in the αCH region of 4DH3 (top in black), 4DH4 
(middle in red) and 4DH5 (bottom in blue).  
 
Figure 4. Dependence of the mean residue molar ellipticity at 222 nm as a function of 4DH3 
concentration in 50 mM buffer acetate at pH 4.6. The error bars indicate the standard deviation of 
three independent experiments. The smoothed curve represents the best fit for the oligomerization 
equation from monomer to tetramer, as reported in the methods section. 
 
Figure 5. 2D 1H DOSY spectrum of 500 µM 4DH3 in D2O, in presence of glycerol as internal 
standard. 
 
Figure 6. Zn2+-binding properties of 4DH3. a) CD spectral changes of a 40 µM 4DH3 solution (as 
monomer concentration) upon addition of ZnSO4 (0.2 eq each) in 10 mM MES buffer pH 6.5. The 
black arrow indicates the observed changes by increasing the metal:peptide ratio up to 2. b) 
Dependence of the mean residue molar ellipticity at 222 nm as a function of metal:peptide ratio. 
The dashed line intersects at the 1:1 ratio.  
 
Figure 7. Size-exclusion chromatography of 4DH3 at pH 6.5 (MES 20 mM, NaCl 200 mM), both 
in the presence (black line) and in the absence (blue line) of 50 µM ZnCl2. In the apo state, two 
single well-resolved peaks are observed, indicative of a momomer-dimer equilibrium. In the 
presence of zinc, a single poorly defined peak is produced. Multi-peak fitting (green lines and red 
dashed lines for the sum) led identification of the aggregation state of the three species under the 
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main peak, resulting in apparent molecular weights corresponding to oligomerization state n = 3.4; 
2.0; 0.9, respectively. 
 
Figure 8. Structural differences among the designed models of 4DH3, 4DH4 and 4DH5. The main 
chain is presented as cartoon, residues in the b and e (on the left) and c and g (on the right) positions 
as sticks. Hydrophobic, polar, negative- and positively-charged residues are coloured in green, 
magenta, red and blue, respectively. Helices 2 and 3 (on the left) and helices 3 and 4 (on the right) 
are transparent to allow a clearer view of the interfaces. 
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Table 1. Far-UV region CD parameters for 4DH3, 4DH4 and 4DH5 at 10 µM concentration in 
H2O. 
 
θ192
a
 θ208
 a
 θ222
 a
 θratio
b 
4DH3 26.57 -14.72 -13.30 0.90 
4DH4 14.49 -11.60 -9.24 0.80 
4DH5 -2.36 -8.53 -3.96 0.46 
a
 The values of θ are reported in kdeg cm2 dmol-1 res-1.  
b
 θratio is the ratio θ222/θ208. 
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Figure 1. Design of tetranuclear clusters in helix bundles. a) D2-symmetrical 4DH analogues, bearing the 
DXXH metal-binding motif, have four Asp and four His residues coordinating 4 ions at the core. Second-shell 
Asp residues at the c-g interface (shown in red) are included to interact with the first-shell His ligands. The 
positions of the three orthogonal two-fold axes are also indicated. b) Crystal structure of 4DH1 (PDB ID 
5WLL): the main chain is presented as cartoon, zinc ions as spheres, and coordinating residues as sticks. c) 
Designed tetranuclear zinc cluster, showing the relative orientations among the carboxylates. d) Model 
structure of 4DH analogues, including the first-shell ligands Asp12 and His16, the second-shell Asp11, and the 
third-shell Arg14. e) Sequence alignment of 4DH analogues. Coordinating residues are in bold, while b and e 
positions in proximity of the metal-binding site are underlined.  
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Figure 2. CD characterization of the three analogues as a function of peptide concentration. a) Comparison 
of far UV CD spectra of 4DH3 (black), 4DH4 (red) and 4DH5 (blue) at 10 µM concentration in H2O. b) 
Comparison of far UV CD spectra of 4DH3 (black), 4DH4 (red) and 4DH5 (blue) at 100 µM concentration in 
H2O. c) Comparison of far UV CD spectra of 4DH3 (black), 4DH4 (red) and 4DH5 (blue) at 1 mM 
concentration in H2O. All experiments were performed in H2O at pH 3.5.  
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Figure 3. NMR characterization of the three analogues, 1 mM in H2O/D2O (90:10 v/v), pH 3.5. a) The 1D 
1H 
NMR spectra in the NH region of 4DH3 (top in black), 4DH4 (middle in red) and 4DH5 (bottom in blue). b) 
The 1D 1H NMR spectra in the αCH region of 4DH3 (top in black), 4DH4 (middle in red) and 4DH5 (bottom in 
blue).  
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Figure 4. Dependence of the mean residue molar ellipticity at 222 nm as a function of 4DH3 concentration 
in 50 mM buffer acetate at pH 4.6. The error bars indicate the standard deviation of three independent 
experiments. The smoothed curve represents the best fit for the oligomerization equation from monomer to 
tetramer, reported in the methods section.  
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Figure 5. 2D 1H DOSY spectrum of 500 µM 4DH3 in D2O, in presence of glycerol as internal standard.  
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Figure 6. Zn2+-binding properties of 4DH3. a) CD spectral changes of 40 µM 4DH3 solution (as monomer 
concentration) upon addition of ZnSO4 (0.2 eq each) in 10 mM MES buffer pH 6.5. The black arrow indicates 
the observed changes by increasing the metal:peptide ratio up to 2. b) Dependence of the mean residue 
molar ellipticity at 222 nm as a function of metal:peptide ratio. The dashed line intersects at the 1:1 ratio.  
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Figure 7. Size-exclusion chromatography of 4DH3 at pH 6.5 (MES 20 mM, NaCl 200 mM), both in the 
presence (black line) and in the absence (blue line) of 50 µM ZnCl2. In the apo state, two single well-
resolved peaks are observed, indicative of a momomer-dimer equilibrium. In the presence of zinc, a single 
poorly defined peak is produced. Multi-peak fitting (green lines and red dashed lines for the sum) led 
identification of the aggregation state of the three species under the main peak, resulting in apparent 
molecular weights corresponding to oligomerization state n = 3.4; 2.0; 0.9, respectively.  
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Figure 8. Structural differences among the designed models of 4DH3, 4DH4 and 4DH5. The main chain is 
presented as cartoon, residues in the b and e (on the left) and c and g (on the right) positions as sticks. 
Hydrophobic, polar, negative- and positively-charged residues are coloured in green, magenta, red and blue, 
respectively. Helices 2 and 3 (on the left) and helices 3 and 4 (on the right) are transparent to allow a 
clearer view of the interfaces.  
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